Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Global Health Investment Corporation (GHIC) is a nonprofit venture capital firm founded in 2012, with a fund size of $108 million. Established with backing from the Bill & Melinda Gates Foundation and JP Morgan Chase, GHIC focuses on mobilizing capital to enhance global public health. The organization operates globally, targeting urgent health challenges in low- and middle-income countries.
GHIC invests in life sciences and healthcare technology companies that address critical global health issues, particularly infectious diseases and maternal and child health. Its primary investment vehicle, the Global Health Investment Fund (GHIF), targets companies developing diagnostics, vaccines, and pharmaceuticals. Check sizes typically align with the fund's social impact goals, focusing on innovations that improve health security.
Notable companies in GHIC's portfolio include Access Bio, Alydia Health, Antheia, Atomo Diagnostics, BD, Biolinq, Centivax, Micron Biomedical, Serum Institute, and Univercells. GHIC also supports initiatives like the Women's and Children's Health Technology Fund and Adjuvant Capital.
Submit your pitch through their website contact form for consideration.
GHIC typically considers follow-on investments for portfolio companies that demonstrate significant progress and alignment with their health impact goals.
GHIC manages the Global Health Investment Fund (GHIF), which has a total size of $108 million.
GHIC uniquely focuses on addressing urgent global health challenges in low- and middle-income countries, leveraging partnerships with organizations like the Bill & Melinda Gates Foundation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.